Innovative Eyewear (LUCY) vs Regentis Biomaterials (RGNT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Regentis Biomaterials is the larger company by market cap ($11.9 million vs $7.8 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LUCY | RGNT |
|---|---|---|
| Share price | $0.8967 | $1.70 |
| Market cap | $7.81M | $11.94M |
| 1-day change | -1.68% | +4.29% |
| YTD return | — | -74.78% |
| EPS (TTM) | $-1.29 | $-2.56 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.05 | $15.50 |
| 52-week low | $0.65 | $1.23 |
| Distance from 52-week high | -56.26% | -89.03% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +488.24% |
| Average volume | 3.81M | 76.78K |
| Shares outstanding | 8.71M | 7.02M |
| Employees | 13 | — |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Innovative Eyewear
LUCY stock →Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names.
Healthcare · Medical Instruments & Supplies · 13 employees
About Regentis Biomaterials
RGNT stock →Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee.
Healthcare · Medical Instruments & Supplies
LUCY vs RGNT FAQ
Which is bigger, Innovative Eyewear or Regentis Biomaterials?
Regentis Biomaterials (RGNT) is larger, with a market capitalization of $11.94M compared with $7.81M for Innovative Eyewear (LUCY).
Are Innovative Eyewear and Regentis Biomaterials in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.